Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1988 3
1989 2
1993 1
1994 1
1999 2
2000 3
2001 4
2002 4
2003 9
2004 13
2005 14
2006 18
2007 11
2008 11
2009 13
2010 11
2011 15
2012 11
2013 12
2014 12
2015 15
2016 18
2017 16
2018 13
2019 11
2020 10
2021 20
2022 8
2023 8
2024 13
2025 13
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

283 results

Results by year

Filters applied: . Clear all
Page 1
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.
Pascual J, Berger SP, Witzke O, Tedesco H, Mulgaonkar S, Qazi Y, Chadban S, Oppenheimer F, Sommerer C, Oberbauer R, Watarai Y, Legendre C, Citterio F, Henry M, Srinivas TR, Luo WL, Marti A, Bernhardt P, Vincenti F; TRANSFORM Investigators. Pascual J, et al. Among authors: bernhardt p. J Am Soc Nephrol. 2018 Jul;29(7):1979-1991. doi: 10.1681/ASN.2018010009. Epub 2018 May 11. J Am Soc Nephrol. 2018. PMID: 29752413 Free PMC article. Clinical Trial.
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands.
Sjögreen Gleisner K, Chouin N, Gabina PM, Cicone F, Gnesin S, Stokke C, Konijnenberg M, Cremonesi M, Verburg FA, Bernhardt P, Eberlein U, Gear J. Sjögreen Gleisner K, et al. Among authors: bernhardt p. Eur J Nucl Med Mol Imaging. 2022 May;49(6):1778-1809. doi: 10.1007/s00259-022-05727-7. Epub 2022 Mar 14. Eur J Nucl Med Mol Imaging. 2022. PMID: 35284969 Free PMC article.
Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer.
Müller C, Umbricht CA, Gracheva N, Tschan VJ, Pellegrini G, Bernhardt P, Zeevaart JR, Köster U, Schibli R, van der Meulen NP. Müller C, et al. Among authors: bernhardt p. Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1919-1930. doi: 10.1007/s00259-019-04345-0. Epub 2019 May 27. Eur J Nucl Med Mol Imaging. 2019. PMID: 31134301 Free PMC article.
Rethinking Dosimetry: A European Perspective.
Tran-Gia J, Cicone F, Koole M, Giammarile F, Gear J, Deshayes E, Minguez Gabiña P, Cremonesi M, Wadsley J, Bernhardt P, Bardiès M, Gnesin S, Sandström M, Garske-Román U, Revheim MR, Verburg FA, Konijnenberg M, Krause BJ, Lassmann M, Stokke C. Tran-Gia J, et al. Among authors: bernhardt p. J Nucl Med. 2025 Sep 2;66(9):1323-1330. doi: 10.2967/jnumed.124.269378. J Nucl Med. 2025. PMID: 40404395 Review.
Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study.
Berger SP, Sommerer C, Witzke O, Tedesco H, Chadban S, Mulgaonkar S, Qazi Y, de Fijter JW, Oppenheimer F, Cruzado JM, Watarai Y, Massari P, Legendre C, Citterio F, Henry M, Srinivas TR, Vincenti F, Gutierrez MPH, Marti AM, Bernhardt P, Pascual J; TRANSFORM investigators. Berger SP, et al. Among authors: bernhardt p. Am J Transplant. 2019 Nov;19(11):3018-3034. doi: 10.1111/ajt.15480. Epub 2019 Jul 1. Am J Transplant. 2019. PMID: 31152476 Free article. Clinical Trial.
Behavioural Addiction: A Concept Analysis.
Crane K, Carman Copel L, Domoff SE, Weissinger G, Bernhardt P, Yost J. Crane K, et al. Among authors: bernhardt p. J Adv Nurs. 2025 Aug;81(8):4584-4590. doi: 10.1111/jan.16969. Epub 2025 Apr 16. J Adv Nurs. 2025. PMID: 40238959 Review.
161Tb Radioimmunotherapy as a Treatment for CD30-Positive Lymphomas.
Rioja-Blanco E, Banz Y, Schlapbach C, Novak U, Chiorazzo T, Bertschi NL, Bernhardt P, Grundler PV, van der Meulen NP, Grzmil M, Schibli R, Behe M. Rioja-Blanco E, et al. Among authors: bernhardt p. J Nucl Med. 2025 Jun 2;66(6):909-915. doi: 10.2967/jnumed.124.268805. J Nucl Med. 2025. PMID: 40456588 Free PMC article.
Comparison of the tolerability of 161Tb- and 177Lu-labeled somatostatin analogues in the preclinical setting.
Busslinger SD, Mapanao AK, Kegler K, Bernhardt P, Flühmann F, Fricke J, Zeevaart JR, Köster U, van der Meulen NP, Schibli R, Müller C. Busslinger SD, et al. Among authors: bernhardt p. Eur J Nucl Med Mol Imaging. 2024 Nov;51(13):4049-4061. doi: 10.1007/s00259-024-06827-2. Epub 2024 Jul 24. Eur J Nucl Med Mol Imaging. 2024. PMID: 39046521 Free PMC article.
Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry.
Gabiña PM, Gleisner KS, Cremonesi M, Stokke C, Flux G, Cicone F, Konijnenberg M, Aldridge M, Sandstrom M, Chiesa C, Paphiti M, Hippeläinen E, Uribe C, Solny P, Gnesin S, Bernhardt P, Chouin N, Costa PF, Glatting G, Verburg F, Gear J. Gabiña PM, et al. Among authors: bernhardt p. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2595-2604. doi: 10.1007/s00259-023-06215-2. Eur J Nucl Med Mol Imaging. 2023. PMID: 37129712 No abstract available.
283 results